Sonnet Biotherapeutics Holdings Inc Net Asset Quality Index
Sonnet Biotherapeutics Holdings Inc net asset quality index. Sonnet Biotherapeutics Holdings Inc (SONN) has a Net Asset Quality Index of -148.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.06 Million minus total liabilities of $5.10 Million yields net assets of $-3.05 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SONN book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sonnet Biotherapeutics Holdings Inc (2007–2025)
Net asset quality index of Sonnet Biotherapeutics Holdings Inc from 2007 to 2025. This chart shows how Sonnet Biotherapeutics Holdings Inc's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2025, the index stands at -148.2%, representing net assets of $-3.05 Million against total assets of $2.06 Million USD. Check SONN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Sonnet Biotherapeutics Holdings Inc Net Asset Quality Index by Year (2007–2025)
Sonnet Biotherapeutics Holdings Inc net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sonnet Biotherapeutics Holdings Inc from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SONN stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.5% | $10.79 Million | $14.88 Million | $4.10 Million | ▲ +90.0 pp |
| 2024 | -17.5% | $-485.74K | $2.77 Million | $3.26 Million | ▼ -13.4 pp |
| 2023 | -4.2% | $-225.98K | $5.43 Million | $5.66 Million | ▲ +39.4 pp |
| 2022 | -43.5% | $-2.54 Million | $5.83 Million | $8.37 Million | ▼ -120.3 pp |
| 2021 | 76.8% | $22.26 Million | $28.99 Million | $6.73 Million | ▲ +39.0 pp |
| 2020 | 37.8% | $3.02 Million | $7.99 Million | $4.97 Million | ▲ +7195.5 pp |
| 2019 | -7157.7% | $-2.85 Million | $39.75K | $2.89 Million | ▼ -7185.5 pp |
| 2018 | 27.7% | $8.26 Million | $29.79 Million | $21.54 Million | ▼ -10.3 pp |
| 2017 | 38.1% | $11.49 Million | $30.18 Million | $18.69 Million | ▼ -3.6 pp |
| 2016 | 41.7% | $13.96 Million | $33.49 Million | $19.52 Million | ▼ -9.9 pp |
| 2015 | 51.6% | $21.76 Million | $42.21 Million | $20.45 Million | ▲ +9.7 pp |
| 2015 | 41.8% | $14.97 Million | $35.79 Million | $20.82 Million | ▼ -14.1 pp |
| 2013 | 55.9% | $11.24 Million | $20.09 Million | $8.85 Million | ▲ +0.0 pp |
| 2013 | 55.9% | $11.24 Million | $20.09 Million | $8.85 Million | ▲ +26.1 pp |
| 2012 | 29.8% | $1.64 Million | $5.50 Million | $3.86 Million | ▲ +24.0 pp |
| 2011 | 5.8% | $82.42 Million | $1.41 Billion | $1.33 Billion | ▼ -43.6 pp |
| 2009 | 49.4% | $718.02K | $1.45 Million | $735.65K | ▼ -19.8 pp |
| 2008 | 69.2% | $1.54 Million | $2.23 Million | $686.12K | ▼ -21.7 pp |
| 2007 | 90.9% | $3.48 Million | $3.82 Million | $349.27K | — |